Moolec Science S.A.(MLEC)Earnings, Financials & Key Ratios
MLEC•NASDAQ
$7.71
Price updated Jul 6, 2026
AboutMoolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.Show more
- Revenue$334M+5830.7%
- EBITDA$12M+246.7%
- Net Income-$111M-1424.3%
- EPS (Diluted)-258.75-8978.9%
- Gross Margin34.17%+306.8%
- EBITDA Margin3.53%+102.5%
- Operating Margin-3.14%+98.0%
- Net Margin-33.41%+74.3%
MLEC Price & Volume
Moolec Science S.A. (MLEC) stock price & volume — 10-year historical chart
Loading chart...
Molecular Farming Transition Faces Severe Liquidity Constraints
Investment Thesis • Updated 2024Q2
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Critical liquidity and dilution
Key Thesis Takeaways
- Moolec Science is currently navigating a high-risk transition from commodity soy processing to a molecular farming biotech model, characterized by persistent operational losses and significant balance sheet erosion.
- While the company pursues long-term innovation, the current financial trajectory is marked by a precarious cash position of $1.9 million and a debt-to-equity ratio that has surged to 7.90.
- Investors should monitor the company's ability to achieve commercial scalability, as the current reliance on external financing and potential for further dilution remains a critical concern for long-term value creation.
Verdict Logic
the company's liquidity buffer has dwindled to $1.9 million against a recurring quarterly net loss, suggesting a high probability of further dilutive capital raises to sustain operations.
MLEC Growth Metrics
Moolec Science S.A. (MLEC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM170.36%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-27.76%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-27.02%
Return on Capital
10 Years-32.13%
5 Years-32.13%
3 Years-52.72%
Last Year-8.76%
Peers Comparison
Key metrics vs top competitors for Moolec Science S.A. (MLEC)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.71 | $5.6M | -0.03 | 5830.74% | -33.41% | — | — | |
| $0.72 | $1.11M | -0.42 | -3.71% | -195.94% | -219.35% | — | |
| $5.60 | $1.68B | -3.97 | 146.73% | -646.99% | -1768.51% | — | |
| $18.36 | $370.97M | -5.70 | 13.09% | -77.96% | -49.3% | — | |
| $0.73 | $340.44M | -0.40 | -15.61% | 92.22% | — | — | |
| $12.96 | $1.17B | 12.71 | 8.98% | -7.46% | -6.15% | — |
Compare MLEC vs Peers
Moolec Science S.A. (MLEC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when MLEC posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
MLEC Frequently Asked Questions
Moolec Science S.A. (MLEC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Moolec Science S.A.'s revenue?
Moolec Science S.A. (MLEC) reported $7.8M in revenue for fiscal year 2024.
How fast is Moolec Science S.A. growing?
Moolec Science S.A. (MLEC) grew revenue by 5830.7% over the past year. This is strong growth.
Is MLEC profitable?
Moolec Science S.A. (MLEC) reported a net loss of $8.3M for fiscal year 2024.
Dividend & Returns
What is Moolec Science S.A.'s free cash flow?
Moolec Science S.A. (MLEC) had negative free cash flow of $6.1M in fiscal year 2024, likely due to heavy capital investments.